Paritaprevir-ritonavir, ombitasvir and dasabuvir plus ribavirin to treat hepatitis C genotype 1 infection after liver transplantation: A single-center experience

Abstract

Hepatitis C virus (HCV) infection is a disease with a significant worldwide impact. In Europe and the United States, chronic hepatitis C is the most common cause of chronic hepatic disease and the main indication for liver transplantation. Recurrent hepatitis C infection is universal among transplant recipients who have detectable viremia at the time of… (More)

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Otero2017ParitaprevirritonavirOA, title={Paritaprevir-ritonavir, ombitasvir and dasabuvir plus ribavirin to treat hepatitis C genotype 1 infection after liver transplantation: A single-center experience}, author={Alejandra Otero and M T V{\'a}zquez and Francisco J. Ozores Su{\'a}rez and Luis Margusino and Sonia D. P{\'e}rtega and Manuel Gomez}, year={2017} }